Personalised wellness platform Answer Genomics secured $500K Pre-Series A funding from IPV
Answer Genomics, a personalized and data-driven wellness platform, has received a $500K pre-series A round of funding from Inflection Point Ventures.
According to a press release from the company, the money will be invested in marketing and sales campaigns as well as initiatives to strategically hire more people to diversify the talent pool.
Answer Genomics, under the direction of Rahul Ranganathan, uses a combination of physical, physiological, and genomic data to paint a picture of one’s current and future health. By analyzing genetic makers using their specialized genomic and machine, it makes predictions about the occurrence, spread, and treatment of clinical and lifestyle disorders.
In order to build a database of genetic data, the company claims to be gathering samples from people with their permission. It uses a small amount of blood and analyzes more than 5 million data points from it to look at different parameters, such as genes, medical history, microbiome, and lifestyle, in order to provide guidance on how to be healthy both now and in the future.
The business also holds publications in significant peer-reviewed journals and has two patent applications pending.
The company received an undisclosed sum from India Accelerator prior to this round in 2021.
